Feature Channels:

OBGYN

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Black, White Men View Impacts of Prostate Cancer Treatment Differently, Study Finds

RonChenHorizontal.jpg

UNC Lineberger Comprehensive Cancer Center surveyed 1,171 men diagnosed with prostate cancer in North Carolina, finding that while both white and black men were concerned about curing their cancer and the quality-of-life impacts of treatment, more black men considered other social and personal factors -- such as recovery time and cost -- to be very important in their treatment decision-making.

Medicine

Channels:

Ethics, Fertility Preservation, Children, DSD, differences of sex development, Disorders of sex development

Is Fertility Preservation Right for Children with Differences of Sex Development?

Children with differences of sex development (DSD) are born with reproductive organs that are not typically male or female. They may face infertility from abnormal development of testes or ovaries, and in some patients these organs are surgically removed to prevent an increased risk of germ cell cancer. With advancing techniques, however, children with DSD may be able to preserve their fertility for the future. This potential also presents important ethical issues, which are examined in an article published in the Journal of the Endocrine Society.

Medicine

Channels:

ASCO, ASCO 2017, ASCO Annual Meeting, PARP, BRCA, Olympiad

Penn Effort to Expand Trials of Olaparib Leads to New Treatment Options for Patients with Advanced BRCA-Related Breast Cancer

Domchek_Susan_white_coat.jpg

Six years ago an international team of physician scientists known as BRCA-TAC led a charge to advance clinical testing of the PARP inhibitor olaparib in cancer patients with known inherited mutations in BRCA1 and BRCA2. This weekend during the plenary session of the American Society of Clinical Oncology Annual Meeting (abstract LBA4), that push comes full circle with the presentation of results of the phase III OlympiAD trial demonstrating for the first time that olaparib is superior to chemotherapy in patients with BRCA-related advanced breast cancer.

Medicine

Channels:

Breast Cancer, immunotheraphy, Metastatic Cancer, pembrolizumab

Immunotherapy Drug Effective for Metastatic Triple Negative Breast Cancer

Immunotherapy trial in metastatic triple negative breast cancer patients proves to shrink tumors in patients.

Medicine

Channels:

Urinary Tract Infections, standard culture, Antibiotics, Bacteria, E. Coli, enhanced quantitative urine culture , EQUC, UTI

Enhanced Test for Urinary Tract Infections Detects More Bacteria Than Standard Test

One of the primary ways physicians diagnose urinary tract infections is with a test that detects bacteria in urine. A new enhanced test detects significantly more bacteria than the standard test, according to a study presented at a meeting of the American Society for Microbiology in New Orleans.

Medicine

Channels:

TNBC, Yale Cancer Center, Breast Cancer, immune therapy, durvalumab/MEDI4736

Immunotherapy Combination Shows Promise in Early Stage Triple Negative Breast Cancer

TNBC2.jpg

Immune checkpoint inhibitor (durvalumab/MEDI4736) with chemotherapy as a preoperative treatment shows promise in early stage TNBC.

Medicine

Channels:

Men's Health, men's health month, Men and alcohol, men and cancer, Men And Doctor Appointments, Men And Hypertension, Men And Skin Cancer, Skin Cancer, Prostate Cancer, Kidney Stone, Diet, Nutrition, Tobacco, Urology, Pulmonary, Memory Disorders, Vitamins

Men: Start Your Path to a Healthier You with 7 Tips

Mens-Health-7-ways-to-get-healthy-graphic.jpg

Physicians at UAB share tips on men’s health and how it affects heart health, sexual function and memory and decreases cancer risk.

Medicine

Channels:

Breast Cancer, Cancer Recurrence, Clinical Trial, Breast Cancer Recurrence, abramson cancer center, Penn Medicine

Slaying the Sleeping Dragon: Researchers Take Action Against Breast Cancer Recurrence

Medicine

Channels:

Genetic Testing, Yale Cancer Center, Cancer Prevention, Breast Cancer, minorities and computer science

Minority Breast Cancer Patients Less Likely to Have Genetic Test

gross.jpg

A genetic test that helps doctors determine how best to treat breast cancer—and whether chemotherapy is likely to help—is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found.

Medicine

Channels:

Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, Autism, Environmental Medicine, Public Health, Autism Spectrum Disorder

Exposure to Specific Toxins and Nutrients During Late Pregnancy and Early Life Correlated with Autism Risk

Mount Sinai study uses a unique source—baby teeth—to reveal that both the timing and amount of exposure can affect diagnosis







Chat now!